The FDA has approved vonoprazan (Voquezna), a new daily treatment for heartburn associated with GERD in adults. andreswd/Getty Images Adults with a certain type of heartburn now have another option ...
Please provide your email address to receive an email when new articles are posted on . Proton pump inhibitors with histamine 2 receptor antagonists reduced all-cause mortality in patients with ...
telemedicine Researchers examined the risks for pneumonia and exacerbation of COPD after PPI treatment for GERD. The risk for symptom exacerbation reduced after PPI treatment for patients with GERD ...
Gilbert Simoni, MD, of Los Robles Hospital in Thousand Oaks, Calif., and founder of Advanced Gastroenterology, Inc. recently performed his 100th transoral incisionless fundoplication (TIF) procedure.
Last month, the Food and Drug Administration (FDA) approved Voquenza Dual (vonoprazan fumarate + amoxicillin) and Triple Paks (vonoprazan fumarate + amoxicillin + clarithromycin) for the treatment of ...
“GERD is a spectrum disease that plagues millions of Americans with frequent symptoms, both objective and subjective, requiring an individualized treatment plan,” said Rohit Agarwal, co-Founder and ...
Idiopathic pulmonary fibrosis (IPF) is a rapidly progressive, fatal disease of unknown cause. Although there is no known cure, there have been indications that gastroesophageal reflux disease (GERD) ...
Broader adoption of MUSE strengthens Medigus' growth potential in Europe following completion of several procedures in leading healthcare institutions Medigus Ltd. (TASE: MDGS), a medical device ...
Each day more than 15 million Americans experience heartburn, also known as acid indigestion, caused by acid from the stomach irritating the esophagus. Normally, the lower part of the esophagus will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results